Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02104050 · ClinicalTrials.gov registry record · Phase 2
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2 study, sponsored by Olatec Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 202
- Enrollment target
NCT02104050: Completed Phase 2 study, sponsored by Olatec Therapeutics.
NCT02104050 is a Phase 2 study that has completed, run by Olatec Therapeutics. The registered enrollment target is 202 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (52% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02104050, a Phase 2 study, has completed, sponsored by Olatec Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 202 participants
- Enrollment target
Study Summary
The objectives of this trial are to investigate the efficacy and safety of six weeks of treatment with OLT1177 Gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy.
Primary Outcome
Subjects will record their level of Pain on Movement in the target knee on a 100-mm VAS scale (with anchors 0=no pain; 100=extreme pain) in response to the question, 'How do you estimate the average amount of your study knee pain while moving during your daily activities within the last 24 hours?'
Interventions
- DRUG Placebo Gel
- DRUG OLT1177 Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-08 |
| Phase | Phase 2 |
What the finished NCT02104050 record still lists
NCT02104050 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (52% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo Gel is the first listed.
NCT02104050 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02104050 about?
NCT02104050 is a clinical study titled "Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain". The objectives of this trial are to investigate the efficacy and safety of six weeks of treatment with OLT1177 Gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy.
What is the current status of trial NCT02104050?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 202 participants. The study started on 2014-04. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02104050?
The interventions under investigation include: Placebo Gel (DRUG), OLT1177 Gel (DRUG).
Who is sponsoring clinical trial NCT02104050?
This trial is sponsored by Olatec Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02104050's enrollment target sits among peer trials
202 301st of 2000 higher than 1,699 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05272254 · 202 participants · Phase 2
Povidone Iodine Efficacy Study
- NCT05701280 · 202 participants · NA
Pilot/Pivotal Study of DBS+Rehab After Stroke
- NCT05932589 · 202 participants
Neurophysiologic Biomarkers in Rett Syndrome
- NCT06014931 · 202 participants · NA
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia